Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus (Q45258803)

11 December 2017

title

Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus (English)

1 reference

11 December 2017

1 reference

Yan J Pang

1

1 reference

11 December 2017

Xiao J Tan

2

1 reference

11 December 2017

Dong M Li

3

1 reference

11 December 2017

Zi H Zheng

4

1 reference

11 December 2017

Rui X Lei

5

1 reference

11 December 2017

Xiao M Peng

6

1 reference

11 December 2017

publication date

25 April 2013

1 reference

11 December 2017

1 reference

11 December 2017

volume

33

1 reference

11 December 2017

issue

8

1 reference

11 December 2017

page(s)

1230-1238

1 reference

Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.

11 December 2017

cites work

1 reference

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

21 January 2018

1 reference

Hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues

21 January 2018

1 reference

Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences

21 January 2018

1 reference

Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme

21 January 2018

1 reference

The hepatitis B virus precore protein is retrotransported from endoplasmic reticulum (ER) to cytosol through the ER-associated degradation pathway

21 January 2018

1 reference

A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen

21 January 2018

1 reference

A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection

21 January 2018

1 reference

Influence of a single nucleotide polymorphism in the P1 promoter of the furin gene on transcription activity and hepatitis B virus infection

21 January 2018

1 reference

Furin at the cutting edge: from protein traffic to embryogenesis and disease

21 January 2018

1 reference

Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases

21 January 2018

1 reference

Polyarginines are potent furin inhibitors

21 January 2018

1 reference

Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes

21 January 2018

1 reference

Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene

21 January 2018

1 reference

Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo

21 January 2018

1 reference

The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo

21 January 2018

1 reference

Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.

21 January 2018

1 reference

Intracellular maturation of the gamma-carboxyglutamic acid (Gla) region in prothrombin coincides with release of the propeptide

21 January 2018

1 reference

Subtilisin-like proprotein convertases, PACE4 and PC8, as well as furin, are endogenous proalbumin convertases in HepG2 cells

21 January 2018

1 reference

Cross-inhibition between furin and lethal factor inhibitors

21 January 2018

1 reference

The C terminus of the hepatitis B virus e antigen precursor is required for a tunicamycin-sensitive step that promotes efficient secretion of the antigen

21 January 2018

1 reference

T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance

21 January 2018

1 reference

Limited redundancy of the proprotein convertase furin in mouse liver

21 January 2018

1 reference

Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics

21 January 2018

1 reference

p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: a mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis

21 January 2018

1 reference

Lactosaminated human albumin, a hepatotropic carrier of drugs.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12185

1 reference

release_5cjzkult7vgjroxg4iw4lijrzi

11 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5cjzkult7vgjroxg4iw4lijrzi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference